FDA: Biotin Interference With Troponin, Lab Tests Still a Concern FDA: Biotin Interference With Troponin, Lab Tests Still a Concern

Some lab test developers have been successful at mitigating the biotin interference of their assays, but others have not yet addressed it, the FDA said in an updated safety alert.News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology News Alert Source Type: news